NeuBase Therapeutics, Inc.
NNASDAQ:NBSECapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- Address
- Similar Companies
- Business
Company News
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
Cheap Penny Stocks To Buy Now? 3 For Your Watch List
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
NeuBase (NBSE) Surges 107% on New Shareholder Acquiring Stake
Why Is NeuBase Therapeutics (NBSE) Stock Down 27% Today?
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?
NeuBase Therapeutics to Explore Strategic Alternatives
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
What Makes NeuBase (NBSE) a New Strong Buy Stock
New Strong Buy Stocks for January 20th
Best Penny Stocks To Buy? 10 Under $1 To Watch This Week
Best Penny Stocks To Buy? 6 Under $1 To Watch Now
NeuBase (NBSE) Up on Restructuring Plan, Set to Lower Workforce
NeuBase (NBSE) Moves to Buy: Rationale Behind the Upgrade
NeuBase to Present at Oppenheimer's 32nd Annual Healthcare Conference
NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference
NeuBase to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
NeuBase Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investment Conference